Expanding Access to Therapy for Childhood Anxiety Disorders Via Smart Phones - PILOT

Stephen Whiteside1 site in 1 country10 target enrollmentJanuary 15, 2016

Overview

Brief Summary

This research study aims to test the feasibility and effectiveness of using the Mayo Clinic Anxiety Coach smartphone app as an addition to traditional therapy for the treatment of anxiety disorders in youth, particularly those youth who may have limited access to mental health treatment in the traditional clinical setting.

Detailed Description

This research study aims to test the feasibility and effectiveness of using the Mayo Clinic Anxiety Coach smartphone app as an addition to traditional therapy for the treatment of anxiety disorders in youth, particularly those youth who may have limited access to mental health treatment in the traditional clinical setting. Therapist will provide CBT to patients with infrequent face-to-face contact and then will examine the acceptability, ease of use and need for contact.

Registry

clinicaltrials.gov

Start Date

January 15, 2016

End Date

March 2017

Last Updated

6 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Stephen Whiteside

Responsible Party

Sponsor Investigator

Principal Investigator

Stephen Whiteside

Associate Professor of Psychology

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

•Age 7 to 17
•Primary diagnosis of:
•social phobia,
•separation anxiety disorder,
•panic disorder with and without agoraphobia,
•specific phobia, or
•obsessive compulsive disorder
•A parent or other primary care giver available to participate with the child in all assessment and treatment activities
•Estimated average intelligence
•English speaking

Exclusion Criteria

•History of and/or current diagnosis of:
•bipolar disorder,
•mental retardation,
•oppositional defiant disorder,
•selective mutism, or
•major depressive disorder
•Current suicidality or recent suicidal behavior
•Parent to be involved in study who is unable to adequately participate due to intellectual or psychiatric difficulties
•Starting or changing the dosage of a psychiatric medication in the last two months

Outcomes

Primary Outcomes

Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion

Time Frame: Within 5 working days of Treatment Completion

The Pediatric Anxiety Rating Scale (PARS) is an interview-based tool used to assess for the presence and severity of anxiety symptoms in children and adolescents utilizing parental and youth input to guide clinician ratings. The PARS has 5 questions. Four of those questions has a scale ranging from none (1) to extreme (5). The other question has a rating of 1-5. The total score ranges from 0 - 25, with 25 being the worst.